ANRO
Alto Neuroscience, Inc.
23.70$
-1.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | – | – | – | – | |
| 69.0% | – | – | – | – | |
| 31.0% | – | – | – | – | |
| 3,985.7% | – | – | – | – | |
| 1,855.2% | – | – | – | – | |
| 5,771.9% | – | – | – | – | |
| -5,741.0% | – | – | – | – | |
| -4,374.8% | – | – | – | – | |
| -4,374.8% | – | – | – | – | |
| -4,305.7% | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.